Alexandra B. Souza - Concepedia

Author

Alexandra B. Souza

Also Known As

Alexandra B Souza, Alexandra B. Souza, Alexandra Brito De Souza, Alexandra Brito Souza, Alexandra Brito de Souza, Alexandra Brito de Souza3, Mayla Mello

Publications

536

Citations

H-Index

Concepts

All Affiliations

Fundação de Medicina Tropical Universidade do Estado do Amazonas Fundação Oswaldo Cruz Universidade Federal do Rio de Janeiro Universidade Salvador

About

Alexandra B. Souza is an author at Fundação de Medicina Tropical specializing in drug resistance, hiv, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	28
2	Pharmacology	1	1	28
3	Antibiotics	1	1	28
4	Drug Resistance	1	1	28
5	Tuberculosis	1	1	28

Alexandra B. Souza

Publications

390

Citations

H-Index

Page 1

	Year	Citations
Factors Associated with Tuberculosis Treatment Default in an Endemic Area of the Brazilian Amazon: A Case Control-Study Marlucia da Silva Garrido, Maria Lúcia Fernandes Penna, Tomàs Maria Pérez-Porcuna, PLoS ONE	2012	83
Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil María B. Arriaga, Gustavo Amorim, Artur T. L. Queiroz, International Journal of Infectious Diseases	2020	49
Predictors of mortality among intensive care unit patients coinfected with tuberculosis and HIV Márcia M. C. Ferreira, Cynthia Pessoa Neves, Alexandra B. Souza, Jornal Brasileiro de Pneumologia	2018	35
Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial Izabella Picinin Safe, Eduardo P. Amaral, Mariana Araújo‐Pereira, Frontiers in Immunology	2021	31
A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes Lauren Peetluk, Peter F. Rebeiro, Felipe Ridolfi, Clinical Infectious Diseases	2021	30
Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study) Izabella Picinin Safe, Marcus Lacerda, Vitoria Silva Printes, PLoS ONE Tuberculosis PreventionPharmacotherapyAntimicrobial ChemotherapyAntiviral DrugDrug Resistance	2020	28
The Effect of Diabetes and Prediabetes on Antituberculosis Treatment Outcomes: A Multicenter Prospective Cohort Study María B. Arriaga, Mariana Araújo‐Pereira, Beatriz Barreto‐Duarte, The Journal of Infectious Diseases	2021	25
Tuberculosis Burden and Determinants of Treatment Outcomes According to Age in Brazil: A Nationwide Study of 896,314 Cases Reported Between 2010 and 2019 Beatriz Barreto‐Duarte, Mariana Araújo‐Pereira, Betânia M. F. Nogueira, Frontiers in Medicine	2021	25
Determinants of losses in the latent tuberculosis infection cascade of care in Brazil Alexandra B. Souza, María B. Arriaga, Gustavo Amorim, BMJ Global Health	2021	21
Anemia and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis: A multi-center prospective cohort study Mariana Araújo‐Pereira, Betânia M. F. Nogueira, Renata Spener-Gomes, Journal of Infection and Public Health	2023	19

Page 1